{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T15:11:32Z","timestamp":1715440292355},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Despite incarcerated population being at an increased risk of tuberculosis (TB) and serving as a potential source of TB transmission for the general population, prison TB remains understudied. Given its adverse impact on progress towards TB elimination, World Health Organization (WHO) has identified prison TB research as a top priority to guide TB treatment\/control interventions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively analyzed 921 notified TB cases that were diagnosed at Kality Federal Prison, Ethiopia during 2009\u20132017. To assess trends of microbiologically confirmed pulmonary TB (PTB), extra-pulmonary TB (EPTB), and TB-HIV co-infection, an ecological analysis of aggregated cases was used to report trends over time. Additionally, we used multivariable log binomial regression to identify patient characteristics associated with microbiologically confirmed PTB,  EPTB, and TB-HIV co-infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Microbiologically confirmed PTB proportion increased over time. Young age was identified as an important risk factor for EPTB (adjusted prevalence ratio [aPR] = 1.74, 95% CI 0.97, 3.13) while HIV coinfection was negatively associated with EPTB (aPR\u2009=\u20090.73, 95% CI 0.55, 0.97). While previous TB history was associated with a lower likelihood of EPTB (aPR\u2009=\u20090.42, 95% CI 0.25, 0.70), it was associated with an increased risk of TB-HIV coinfection (aPR\u2009=\u20091.37, 95% CI 1.10, 1.71). Clinically diagnosed PTB patients were more likely to have TB-HIV coinfection compared to microbiologically confirmed PTB patients (aPR\u2009=\u20091.32, 95% CI 1.02, 1.72).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Increasing proportion of microbiologically confirmed PTB may suggest delayed access to treatment, severe disease and increased risk of intramural transmission. Associations with clinical\/demographic factors varied for different types of TB and were not always consistent with what has been previously reported for the general population, necessitating the need to refocus prison TB control\/treatment strategies based on context specific epidemiological factors.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-021-01699-w","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T13:03:45Z","timestamp":1635339825000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Patient characteristics associated with different types of prison TB: an epidemiological analysis of 921\u00a0TB cases diagnosed at an Ethiopian prison"],"prefix":"10.1186","volume":"21","author":[{"given":"Asmah","family":"Amirkhani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maheen","family":"Humayun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoseph","family":"Worku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"key":"1699_CR1","unstructured":"World Health Organization. Global tuberculosis report 2020. Geneva; 2020 [cited 2021 Apr 25]. Available from https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/336069\/9789240013131-eng.pdf."},{"key":"1699_CR2","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1086\/651475","volume":"50","author":"KH Mayer","year":"2010","unstructured":"Mayer KH, Hamilton CD. Synergistic pandemics: confronting the global HIV and tuberculosis epidemics. Clin Infect Dis. 2010;50:S67\u201370.","journal-title":"Clin Infect Dis"},{"key":"1699_CR3","doi-asserted-by":"crossref","unstructured":"Cha J, Thwaites GE, Ashton PM. An evaluation of progress towards the 2035 WHO End TB targets in 40 high burden countries. medRxiv. 2020.","DOI":"10.1101\/2020.10.02.20175307"},{"issue":"11","key":"1699_CR4","doi-asserted-by":"publisher","first-page":"e806","DOI":"10.1016\/S2214-109X(16)30199-1","volume":"4","author":"RMGJ Houben","year":"2016","unstructured":"Houben RMGJ, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, et al. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Lancet Glob Heal. 2016;4(11):e806\u201315.","journal-title":"Lancet Glob Heal"},{"issue":"1","key":"1699_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13690-017-0204-x","volume":"75","author":"A Melese","year":"2017","unstructured":"Melese A, Demelash H. The prevalence of tuberculosis among prisoners in Ethiopia: a systematic review and meta-analysis of published studies. Arch Public Health. 2017;75(1):1\u20139.","journal-title":"Arch Public Health"},{"key":"1699_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijid.2014.12.029","volume":"32","author":"M Dara","year":"2015","unstructured":"Dara M, Acosta CD, Melchers NVSV, Al-Darraji HAA, Chorgoliani D, Reyes H, et al. Tuberculosis control in prisons: current situation and research gaps. Int J Infect Dis. 2015;32:111\u20137.","journal-title":"Int J Infect Dis"},{"key":"1699_CR7","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1017\/S095026881400288X","volume":"143","author":"F Biadglegne","year":"2015","unstructured":"Biadglegne F, Rodloff AC, Sack U. Review of the prevalence and drug resistance of tuberculosis in prisons: a hidden epidemic. Epidemiol Infect. 2015;143:887\u2013900.","journal-title":"Epidemiol Infect"},{"key":"1699_CR8","unstructured":"World Health Organization. Prisons and health. Stefan Enggist, Lars M\u00f8ller, Gauden Galea CU, editor. 2014 [cited 2021 Apr 25]. Available from https:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0005\/249188\/Prisons-and-Health.pdf."},{"key":"1699_CR9","unstructured":"Dara M, Grzemska M, Kimerling ME, Reyes H, Zagorskiy A. Guidelines for control of tuberculosis in prisons. 2009 [cited 2021 Apr 25]. Available from https:\/\/www.challengetb.org\/publications\/tools\/ua\/Guidelines_for_control_of_TB_in_prisons.pdf."},{"issue":"12","key":"1699_CR10","doi-asserted-by":"publisher","first-page":"e100038","DOI":"10.1371\/journal.pmed.1000381","volume":"7","author":"I Baussano","year":"2010","unstructured":"Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis incidence in prisons: a systematic review. PLoS Med. 2010;7(12):e100038.","journal-title":"PLoS Med"},{"issue":"8","key":"1699_CR11","first-page":"696","volume":"5","author":"K Fernandez de la Hoz","year":"2001","unstructured":"Fernandez de la Hoz K, I\u00f1igo J, Fernandez-Mart\u00edn JI, Arce A, Alonso-Sanz M, Gomez-Pintado P, et al. The influence of HIV infection and imprisonment on dissemination of Mycobacterium tuberculosis in a large Spanish city. Int J Tuberc Lung Dis. 2001;5(8):696\u2013702.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1699_CR12","unstructured":"Priorities for tuberculosis research: A report of the Disease reference group on TB, leprosy and Buruli ulcer. 2013 [cited 2021 Apr 25]. Available from https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/85888\/9789241505970_eng.pdf?sequence=1."},{"issue":"12","key":"1699_CR13","doi-asserted-by":"publisher","first-page":"e0226160","DOI":"10.1371\/journal.pone.0226160","volume":"14","author":"ET Sahle","year":"2019","unstructured":"Sahle ET, Blumenthal J, Jain S, Sun S, Young J, Manyazewal T, et al. Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: prevalence from screening of entrant and resident prisoners. PLoS ONE. 2019;14(12):e0226160.","journal-title":"PLoS ONE"},{"key":"1699_CR14","unstructured":"Reves R, Angelo S. As Ethiopia moves toward tuberculosis elimination, success requires higher investment. Center for Strategic and International Studies (CSIS). 2016 [cited 2021 Apr 25]. Available from http:\/\/www.jstor.org\/stable\/resrep23951.5."},{"issue":"1","key":"1699_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12890-019-0853-3","volume":"19","author":"NS Kirirabwa","year":"2019","unstructured":"Kirirabwa NS, Kimuli D, Nanziri C, Sama D, Ntudhu S, Okello DA, et al. A 4-year trend in pulmonary bacteriologically confirmed tuberculosis case detection in Kampala\u2013Uganda. BMC Pulm Med. 2019;19(1):91.","journal-title":"BMC Pulm Med"},{"key":"1699_CR16","unstructured":"New South Wales Ministry of Health. National Guidelines for the Public Health Management of TB. 2014 [cited 2021 Apr 25]. Available from http:\/\/www.health.nsw.gov.au\/Infectious\/controlguideline\/Documents\/TB-SoNG-2013-NSW-edits.pdf."},{"key":"1699_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41586-019-00857-9","volume":"567","author":"V Amrhein","year":"2019","unstructured":"Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature. 2019;567:305\u20137.","journal-title":"Nature"},{"key":"1699_CR18","unstructured":"World Health Organization. Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. 2007 [cited 2021 Apr 25]. Available from http:\/\/www.who.int\/hiv\/pub\/tb\/pulmonary\/en\/."},{"key":"1699_CR19","doi-asserted-by":"publisher","first-page":"20960","DOI":"10.7448\/IAS.19.1.20960","volume":"19","author":"CL Edge","year":"2016","unstructured":"Edge CL, King EJ, Dolan K, McKee M. Prisoners co-infected with tuberculosis and HIV: a systematic review. J Int AIDS Soc. 2016;19:20960.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"1699_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1183\/09031936.05.00136004","volume":"26","author":"FA Drobniewski","year":"2005","unstructured":"Drobniewski FA, Balabanova YM, Ruddy MC, Graham C, Kuznetzov SI, Gusarova GI, et al. Tuberculosis, HIV seroprevalence and intravenous drug abuse in prisoners. Eur Respir J. 2005;26(2):298.","journal-title":"Eur Respir J"},{"issue":"9","key":"1699_CR21","doi-asserted-by":"publisher","first-page":"e73717","DOI":"10.1371\/journal.pone.0073717","volume":"8","author":"HAA Al-Darraji","year":"2013","unstructured":"Al-Darraji HAA, Razak HA, Ng KP, Altice FL, Kamarulzaman A. The Diagnostic performance of a single GeneXpert MTB\/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in Malaysia. PLoS ONE. 2013;8(9):e73717.","journal-title":"PLoS ONE"},{"issue":"5","key":"1699_CR22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/QAI.0b013e318196761c","volume":"50","author":"S Shah","year":"2009","unstructured":"Shah S, Demissie M, Lambert L, Ahmed J, Leulseged S, Kebede T, et al. Intensified tuberculosis case finding among HIV-infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia. J Acquir Immune Defic Syndr. 2009;50(5):537\u201345.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"1699_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4269\/ajtmh.19-0856","volume":"103","author":"RJ Martino","year":"2020","unstructured":"Martino RJ, Chirenda J, Mujuru HA, Ye W, Yang Z. Characteristics indicative of tuberculosis\/HIV coinfection in a high-burden setting: lessons from 13,802 incident tuberculosis cases in Harare, Zimbabwe. Am J Trop Med Hyg. 2020;103(1):214\u201320.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"1699_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41426-018-0106-1","volume":"7","author":"X Qian","year":"2018","unstructured":"Qian X, Nguyen DT, Lyu J, Albers AE, Bi X, Graviss EA. Risk factors for extrapulmonary dissemination of tuberculosis and associated mortality during treatment for extrapulmonary tuberculosis article. Emerg Microbes Infect. 2018;7(1):1\u201314.","journal-title":"Emerg Microbes Infect."},{"issue":"12","key":"1699_CR25","doi-asserted-by":"publisher","first-page":"e112213","DOI":"10.1371\/journal.pone.0112213","volume":"9","author":"X Wang","year":"2014","unstructured":"Wang X, Yang Z, Fu Y, Zhang G, Wang X, Zhang Y, et al. Insight to the epidemiology and risk factors of extrapulmonary tuberculosis in Tianjin, China during 2006\u20132011. PLoS ONE. 2014;9(12):e112213.","journal-title":"PLoS ONE"},{"issue":"6","key":"1699_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1080\/15321819.2018.1529681","volume":"39","author":"IO Okonko","year":"2018","unstructured":"Okonko IO, Anyanwu A, Osadebe AU, Odu NN. HIV and tuberculosis co-infection in a highly HIV-infected population of rivers state, Nigeria. J Immunoass Immunochem. 2018;39(6):636\u201346.","journal-title":"J Immunoass Immunochem"},{"issue":"7","key":"1699_CR27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1089\/aid.2012.0239","volume":"29","author":"ZC M\u00e9da","year":"2013","unstructured":"M\u00e9da ZC, Sombi\u00e9 I, Sanon OWC, Mar\u00e9 D, Morisky DE, Chen YMA. Risk factors of tuberculosis infection among HIV\/AIDS patients in Burkina Faso. AIDS Res Hum Retroviruses. 2013;29(7):1045\u201355.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"1699_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-019-7980-x","volume":"19","author":"A Tola","year":"2019","unstructured":"Tola A, Mishore KM, Ayele Y, Mekuria AN, Legese N. Treatment outcome of tuberculosis and associated factors among TB-HIV co-infected patients at public hospitals of Harar Town, Eastern Ethiopia. A 5-year retrospective study. BMC Public Health. 2019;19(1):1\u201312.","journal-title":"BMC Public Health"},{"issue":"2","key":"1699_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1086\/380644","volume":"38","author":"Z Yang","year":"2004","unstructured":"Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis. 2004;38(2):199\u2013205.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1699_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/oem.55.4.272","volume":"55","author":"ML Thompson","year":"1998","unstructured":"Thompson ML, Myers JE, Kriebel D. Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done? Occup Environ Med. 1998;55(4):272\u20137.","journal-title":"Occup Environ Med"},{"issue":"NOV","key":"1699_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fvets.2017.00193","volume":"4","author":"BA Fonseca Martinez","year":"2017","unstructured":"Fonseca Martinez BA, Leotti VB, de Sousa e Silva G, Nunes LN, Machado G, Corbellini LG. Odds ratio or prevalence ratio? An overview of reported statistical methods and appropriateness of interpretations in cross-sectional studies with dichotomous outcomes in veterinary medicine. Front Vet Sci. 2017;4(NOV):193.","journal-title":"Front Vet Sci"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01699-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-021-01699-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01699-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T13:03:59Z","timestamp":1635339839000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-021-01699-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1699"],"URL":"https:\/\/doi.org\/10.1186\/s12890-021-01699-w","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"7 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the University of Michigan Institutional Review Board\u2014Health Science and Behavior Sciences, the St. Paul\u2019s Hospital Millennium Medical College Institutional Review Board, and the Kality Prison Administration. All the analyses of the present study used existing de-identified data and this study involved no interactions with the study patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"334"}}